Americafirst Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-46,841	Closed	-$734M	–	266
2014 Q3	$734M	Buy	+46,841	New	+$734M	0.36%	98